Delivery Order SPE2DB22D3501-SPE2DB24FWW60
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.15 firm fixed-price contract is for the supply of the medication "ZORYVE 0.3% CREAM 60GM" and has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,294.33 firm fixed-price delivery order covers the supply of ZORYVE 0.3% Cream, a pharmaceutical product, with a period of performance through April 5, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract is a delivery order valued at $9,292.68 for the supply of the pharmaceutical product ZORYVE 0.3% Cream 60GM. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORYVE 0.3% Cream, a pharmaceutical product, with a ceiling value of $8,709.68 and a performance period through May 9, 2025. The contract is a firm-fixed-price type and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,149.04, is a delivery order for the medication "ZORYVE 0.3% CREAM 60GM" with an ultimate completion date of April 30, 2025. The contract is not set-aside and was awarded on a firm fixed-price basis. Amerisourcebergen Drug Corp is the prime contractor and holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,130.98 firm fixed-price delivery order covers the supply of ZORYVE 0.3% Cream, a pharmaceutical product, to support federal healthcare programs. The contract is not designated with a set-aside requirement, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,182.21 firm fixed-price delivery order is for the supply of ZORYVE 0.3% cream in 60 gram units, with a completion date of May 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB25FTX53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,799.19 delivery order is for the supply of ZORYVE 0.3% CREAM 60GM, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of December 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB25D3504|SPE2DB25FVTYL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,133.72 firm fixed price delivery order is for the supply of ZORYVE 0.3% cream, a pharmaceutical product. The contract has an ultimate completion date of March 26, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.15% cream in 60 gram quantities, with a ceiling value of $2,662.56 and a period of performance through June 5, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...